Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Copenhagen, Denmark
Countries of investment
  • Denmark
Investment stages
  • Seed
  • Series A
Industries
  • Health Tech
About
LEO Innovation Lab, a pioneering initiative established by LEO Pharma, is committed to enhancing the quality of life for individuals suffering from chronic skin conditions. By concentrating on patient-centric solutions, the lab not only supports the development of innovative therapies but also fosters and invests in startups that demonstrate disruptive potential in healthcare. Through collaboration and cutting-edge research, LEO Innovation Lab aims to drive advancements in dermatological care, ensuring that patients receive more effective treatments tailored to their unique needs.
Min check size
$100K
Max check size
$2M
Fund size
NPS

Investment Thesis

Specializes in investments in health tech and life sciences startups, with an emphasis on innovative solutions and patient outcomes.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With extensive experience in venture capital, the fund manager has successfully led numerous investments across technology and healthcare sectors, primarily in North America and Europe. Having executed over 50 deals, their strategic approach emphasizes a data-driven methodology, focusing on early-stage opportunities with high growth potential. Notable exits include multiple high-profile acquisitions, showcasing their ability to identify and nurture transformative companies. Their operator-first mindset ensures a hands-on approach to portfolio management, enhancing value creation throughout the investment lifecycle.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp